Adaptive Biotechnologies Corp
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About ADPT
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. It applies its platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across its two business segments: Minimal Residual Disease (MRD) and Immune Medicine. The MRD business focuses on the use of its sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. Its MRD business is comprised of its clonoSEQ clinical diagnostic test, offered to clinicians. The IM business focuses on the discovery and development of transformative immune-based therapies in the treatment of patients with cancer and autoimmune diseases.
Find out what a historical investment in Adaptive Biotechnologies Corp would be worth today using our ADPT stock calculator.
$1.37B
-
0.00%
964.17K
$9.12
$8.81
$8.95
$10.28
$2.99
Ready to start your investing journey with Stake?
Open an accountADPT FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ADPT
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ADPT
on Stake
Buy ADPT from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of ADPT from only US$10 with fractional shares
